| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 11/15/2006 | CN1864434A Wireless microphone communication system |
| 11/15/2006 | CN1863905A Method and composition for enhancing in vitro embryo development by supplementing culture medium with prostaglandin or a prostaglandin analog |
| 11/15/2006 | CN1863866A Finely particulate composite containing carbon compound encapsulated therein |
| 11/15/2006 | CN1863813A Novel tricyclic nucleosides or nucleotides as therapeutic agents |
| 11/15/2006 | CN1863812A Polymorphic antiviral nucleoside compounds |
| 11/15/2006 | CN1863811A Stable vitamin B6 derivative |
| 11/15/2006 | CN1863810A Derivatives of [2-(8,9-dioxo-2,6-diazabicyclo[5.2.0]non-1(7)-en-2-yl)alkyl] phosphonic acid and methods of use thereof |
| 11/15/2006 | CN1863805A Disulfide, sulfide, sulfoxide, and sulfone derivatives of cyclic sugars and uses thereof |
| 11/15/2006 | CN1863803A 嘧啶衍生物 Pyrimidine derivatives |
| 11/15/2006 | CN1863801A Imidazopyridine substituted tropane derivatives with ccr5 receptor antagonist activity for the treatment of HIV and inflammation |
| 11/15/2006 | CN1863799A Chroman carboxylic acid derivatives for the treatment of diabetes and lipid disorders |
| 11/15/2006 | CN1863798A 2,4-dioxo-3-quinazolinylaryl sulfonylureas |
| 11/15/2006 | CN1863797A Cyclic amine BACE-1 inhibitors having a benzamide substituent |
| 11/15/2006 | CN1863796A Salts and polymorphs of a pyrrole-substituted indolinone compound |
| 11/15/2006 | CN1863794A Quinazoline derivatives as angiogenesis inhibitors |
| 11/15/2006 | CN1863792A Novel farnesyl protein transferase inhibitors as antitumor agents |
| 11/15/2006 | CN1863791A Novel crystalline forms of {2-[1-(3,5-bis-trifluoromethylbenzyl)-5-pyridin-4-yl-1h-[1,2,3]triazol-4-yl]-pyridin-3-yl}-(2-chlorophenyl)-methanone |
| 11/15/2006 | CN1863790A Therapeutic agents useful for treating pain |
| 11/15/2006 | CN1863789A Substituted isoquinolinones |
| 11/15/2006 | CN1863788A Substances of antimicrobial, antifungoid and antiprotozoan activities |
| 11/15/2006 | CN1863784A 2-naphthylimino-1,3-thiazine derivative |
| 11/15/2006 | CN1863783A Compounds having thrombopoietin receptor agonism |
| 11/15/2006 | CN1863782A 2-(quinoxalin-5-ylsulfonylamino)-benzamide compounds as cck2 modulators |
| 11/15/2006 | CN1863781A 2-(quinoxalin-5-ylsulfonylamino)-benzamide compounds as cck2 modulators |
| 11/15/2006 | CN1863780A Protein kinase inhibitors and uses thereof |
| 11/15/2006 | CN1863779A Novel indazole derivative |
| 11/15/2006 | CN1863778A Compounds and methods for treating dyslipidemia |
| 11/15/2006 | CN1863776A Crystalline form of gatifloxacin |
| 11/15/2006 | CN1863775A Substituted pentanols, a process for their production and their use as anti-inflammatory agents |
| 11/15/2006 | CN1863774A Compounds and compositions as protein kinase inhibitors |
| 11/15/2006 | CN1863773A 四氢吡啶衍生物 Tetrahydropyridine derivatives |
| 11/15/2006 | CN1863771A Sequence selective pyrrole and imidazole polyamide metallocomplexes |
| 11/15/2006 | CN1863768A 8-aza-11-deoxy prostaglandin analogues |
| 11/15/2006 | CN1863763A Inhibitors of semicarbazide-sensitive amine oxidase (SSAO) and vap-1 mediated adhesion useful for treatment of diseases |
| 11/15/2006 | CN1863558A Polyarginine-modified liposome capable of transferring into nucleus |
| 11/15/2006 | CN1863557A In-situ gelling drug delivery system |
| 11/15/2006 | CN1863551A Use of PLP with PEG-rMETase in vivo for enhanced efficacy |
| 11/15/2006 | CN1863542A Plant seed extract composition and process for producing the same |
| 11/15/2006 | CN1863540A Method to treat the side effects associated with non steroidal anti-inflammatory drugs using microorganisms of the genus bifidobacterium |
| 11/15/2006 | CN1863539A Buffered compositions for dialysis |
| 11/15/2006 | CN1863538A Nucleoside derivatives for treating hepatitis c virus infection |
| 11/15/2006 | CN1863537A Extended triphasic contraceptive regimens |
| 11/15/2006 | CN1863536A Sigma-1 receptor ligand with acetylcholinesterase |
| 11/15/2006 | CN1863535A Noncrystalline antibacterial composition containing cefditoren pivoxil |
| 11/15/2006 | CN1863534A Quinazoline derivatives as inhibitors of vegf receptor tyrosine kinases |
| 11/15/2006 | CN1863533A No title available |
| 11/15/2006 | CN1863532A Aza spiro alkane derivatives as inhibitors of metalloproteases |
| 11/15/2006 | CN1863531A Treatment for cd5+ b cell lymphoma |
| 11/15/2006 | CN1863530A (3,4-phenyl)piperidin-3-yl- phenylcarboxylate derivatives and related compounds as beta-secretase inhibitors for the treatment of alzheimer's disease |
| 11/15/2006 | CN1863529A Topical compositions comprising telmesteine for treating dermatological disorders |
| 11/15/2006 | CN1863528A Indoles and azaindoles as antiviral agents |
| 11/15/2006 | CN1863527A 1-sulfonylindole derivatives, their preparation and their use as 5-ht6 ligands |
| 11/15/2006 | CN1863526A Collagen productin enhancer and production process and use thereof |
| 11/15/2006 | CN1863525A Protective and therapeutic uses for tocotrienols |
| 11/15/2006 | CN1863524A Neutralizing agent for cavitating toxin |
| 11/15/2006 | CN1863523A Application of L-NBP in preparation of medicine for preventing and curing celebralin farction |
| 11/15/2006 | CN1863522A Ophthalmic composition for treating lacrimal disorders |
| 11/15/2006 | CN1863521A Method for decreasing sebum production |
| 11/15/2006 | CN1863520A Alfavbeta3 and alfavbeta6 integrin antagonists as antifibrotic agents |
| 11/15/2006 | CN1863518A Pharmaceutical composition containing fenofibrate and method for the preparation thereof |
| 11/15/2006 | CN1863517A Rapidly disintegrating formulation |
| 11/15/2006 | CN1863514A Abuse-proffed dosage form |
| 11/15/2006 | CN1863513A Abuse-proffed dosage form |
| 11/15/2006 | CN1863511A Dosage forms of cholesteryl ester transfer protein inhibitors and hmg-coa reductase inhibitors |
| 11/15/2006 | CN1863509A Pharmaceutical multiparticulate composition comprising mycophenolic acid or mycophenolate sodium and combination with rapamycin |
| 11/15/2006 | CN1863505A Novel liquid preparation composition |
| 11/15/2006 | CN1861640A Preparation process of chito oligosaccharace hydrochloride |
| 11/15/2006 | CN1861637A Preparation process of Huai Chinese yam polysaccharose and use thereof |
| 11/15/2006 | CN1861627A 23-Hydroxyl betulinic acid kind derivant and preparing process, preparation and use thereof |
| 11/15/2006 | CN1861626A Metallic salt kind medicine containing glycyrrhizic hypoglycyrrhizic or its derivant and preparation process thereof |
| 11/15/2006 | CN1861623A Asparagic acid azithromycin and preparation thereof |
| 11/15/2006 | CN1861622A Macrocyclolactone lactone kind medicine erythromycin A derivant, synthesizing process and use thereof |
| 11/15/2006 | CN1861621A Process of preparing burdock glucoside and glucosidgen thereof |
| 11/15/2006 | CN1861610A Synthesizing of Demethylcantharidin-neodymium |
| 11/15/2006 | CN1861608A Crystalline solvate of cefuroxime acid |
| 11/15/2006 | CN1861605A Fleshy glossy ganoderma lactone A, preparation process and use thereof |
| 11/15/2006 | CN1861604A Crystal form of asenapine maleate |
| 11/15/2006 | CN1861603A Silicon phthalocyanine compound and composite, their preparation and application thereof |
| 11/15/2006 | CN1861599A Quinone carboxylic acid kind derivant, it preparation process and medicine application |
| 11/15/2006 | CN1861597A Internal ester monomer compound and its application in preparing anti cancer medicine |
| 11/15/2006 | CN1861595A Brugine cyclo hexathio-alcohol kind compound, its preparation process and use |
| 11/15/2006 | CN1861591A Hesperetin derivant and preparation process thereof |
| 11/15/2006 | CN1861590A Flavoneoid derivative and its preparation process and use |
| 11/15/2006 | CN1861588A Internal ester monomer compound and application in preparing anti cancer medicine |
| 11/15/2006 | CN1861587A Internal ester monomer compound and application in preparing anti cancer medicine |
| 11/15/2006 | CN1861582A Cyclopropyl substituded triazol kind anti fungus compound and preparation process and use thereof |
| 11/15/2006 | CN1861581A Preparation of allantoin and allantoin extract from cistanche salsa and their use thereof |
| 11/15/2006 | CN1861558A Process of extracting cimitt acid |
| 11/15/2006 | CN1861555A Triphenylalkene derivatives and their use as selective estrogen receptor modulators |
| 11/15/2006 | CN1861193A Kidney target precursor medicine, said prepn., its preparing method and application |
| 11/15/2006 | CN1861192A Camptothecin type medicine loaded on high molecular nano-microsphere, and its prepn. method |
| 11/15/2006 | CN1861184A Application of composition for preparing medicine to treat chilblain disease |
| 11/15/2006 | CN1861176A Medicinal composition for treating diabets, and its prepn. method |
| 11/15/2006 | CN1861152A Health-care medicine for lowering content of cholesterol and triglyceride in blood |
| 11/15/2006 | CN1861131A Qingkailing dixinwan pill prepn. and its prepn. method |
| 11/15/2006 | CN1861110A Medicated prepn. for lowering blood-pressure and treating wind, and its prepn. method |
| 11/15/2006 | CN1861107A Thin coating medicine for treating cold and its prepn. method |
| 11/15/2006 | CN1861100A External use oil agent for treating proliferation of mammary gland and its prepn. method |
| 11/15/2006 | CN1861092A Application of chlorine-contg. disinfectant in pharmaceutics |
| 11/15/2006 | CN1861090A Toxicity-expelling fibrous nutrient and its prepn. method |